Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas

Introduction: Hematopoietic neoplasms are often driven by gain-of-function mutations of the JAK-STAT pathway together with mutations in chromatin remodeling and DNA damage control pathways. The interconnection between the JAK-STAT pathway, epigenetic regulation or DNA damage control is still poorly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Expert Opin Ther Targets
Main Authors: Orlova, Anna, Wingelhofer, Bettina, Neubauer, Heidi A., Maurer, Barbara, Berger-Becvar, Angelika, Keserű, György Miklós, Gunning, Patrick T., Valent, Peter, Moriggl, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5743003/
https://ncbi.nlm.nih.gov/pubmed/29148847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728222.2018.1406924
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados